Chemoinformaics analysis of (6E)-2,6-DIMETHYL-10-METHYLIDENEDODECA-2,6-DIENE
| Molecular Weight | 206.373 | nRot | 7 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 2 |
| Exact Molecular Weight | 206.203 | nRing | 0 |
| Solubility: LogS | -3.609 | nHRing | 0 |
| Solubility: LogP | 4.18 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 42.3866 |
| nHD | 0 | BPOL | 26.0834 |
| QED | 0.3 |
| Synth | 2.353 |
| Natural Product Likeliness | 1.626 |
| NR-PPAR-gamma | 0.516 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.008 |
| HIA | 0.005 |
| CACO-2 | -4.504 |
| MDCK | 0.0000183 |
| BBB | 0.993 |
| PPB | 0.700688 |
| VDSS | 2.138 |
| FU | 0.138057 |
| CYP1A2-inh | 0.85 |
| CYP1A2-sub | 0.315 |
| CYP2c19-inh | 0.311 |
| CYP2c19-sub | 0.168 |
| CYP2c9-inh | 0.228 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.102 |
| CYP2d6-sub | 0.341 |
| CYP3a4-inh | 0.195 |
| CYP3a4-sub | 0.083 |
| CL | 5.78 |
| T12 | 0.388 |
| hERG | 0.135 |
| Ames | 0.145 |
| ROA | 0.015 |
| SkinSen | 0.977 |
| Carcinogencity | 0.431 |
| EI | 0.984 |
| Respiratory | 0.901 |
| NR-Aromatase | 0.131 |
| Antiviral | Yes |
| Prediction | 0.768973 |